In addition, we demonstrate that ex vivo metastatic progression is reduced in the lungs of ELP-/- mice compared to wild-type mice and that treatment with the pan-selectin inhibitor bimosiamose reduces lung-specific TN breast cancer migration and proliferation in vitro. This evidence concerns the gene NR5A1 and breast carcinoma.